The shares of Itau Unibanco Holding S.A. (NYSE:ITUB) has performed better over the past three months, as it added around 33.08% while it has so far climbed around 14.58% during the course of a year. It went up by $0.06 now trading at $9.2. Their shares witnessed a 41.32% increase from the 52-week low price of $6.51 they recorded on 2018-09-13. Even though it is still -23.04% behind the $11.32 high touched on 2018-01-26. The last few days have been rough for the stock, as its price has decreased by -1.08% during the week. The stock of ITUB recorded 12.41% uptrend from the beginning of this year till date. The 12-month potential price target for Itau Unibanco Holding S.A. is set at $8.93. This target means that the stock has an upside potential to increase by -2.93% from the current trading price.
When giving their opinion, around 33.33% of Wall Street analysts, which represents 2 out of 6 rated the stock as a Buy. 4 brokerage firms of the remaining 66.67% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate ITUB shares held by institutional investors represents 26.8% of total shares. 44 institutions entered new Itau Unibanco Holding S.A. (NYSE:ITUB) positions, 137 added to their existing positions in these shares, 160 lowered their positions, and 48 exited their positions entirely.
Itau Unibanco Holding S.A. (ITUB) trade volume has decreased by -33.33% as around 16,744,571 shares were sold when compared with its 50-day average volume of traded shares which is 25,114,957. At the moment, ITUB is witnessing a uptrend, as it is trading 1.22% above its 20-day SMA, 6.14% above its 50-day SMA, and 9.43% above its 200-day SMA. The company runs an ROE of roughly 18.6%, with financial analysts predicting that their earnings per share growth will be around 9.3% per annum for the next five year. This will be compared to the 5.5% increase witnessed over the past five years.
The first technical resistance point for Itau Unibanco Holding S.A. (NYSE:ITUB) will likely come at $9.37, marking a 1.81% premium to the current level. The second resistance point is at $9.55, about 3.66% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $8.61, the lower end of the range. ITUB’s 14-day MACD is 0.03 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 55.61, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 31.45 percent, which is low when compared to that of the 50-day’s 40.78 percent.
The shares of Boston Scientific Corporation (NYSE:BSX) has increased by 0.68%, and now trading at $36.77 on the Wall Street in the intra-day deal, with their shares traded now around 9,549,287. This is a rise of 1,600,527 shares over the average 7,948,760 shares that were traded daily over the last three months. The stock that is trading at $36.77 went higher by 49.84% from its 52-week low of $24.54 that it attained back on 2017-12-29. The stock recorded a 52-week high of $39.44 nearly 66 days ago on 2018-10-02.
BSX stock has performed well over the past 30 days, as it added 1.13% while its price climbed by 48.33% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 0.33% over the last week. The stock’s 12-month potential target price is now at $42.41. This means that the stock price might likely increase by 15.34% from its current trading price.21 out of 23 Wall Street analysts which represents 91.3% rated the stock as a buy while the remaining 8.7 rated it as a hold, with 0 of analysts rating it as a sell.
Boston Scientific Corporation (NYSE:BSX) has been utilizing an ROE that is roughly 8.9%, with stock analysts predicting that the company’s EPS for the next five years will go up by 10.46% per year, following the 17.5% raise that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 0.64% above its 20-day SMA, -0.4% below its 50-day SMA, and 12.06% above its 200-day SMA. In percentage terms, the aggregate Boston Scientific Corporation shares held by institutional investors is 93.7%. 93 institutions jumped in to acquire Boston Scientific Corporation (BSX) fresh stake, 323 added to their current holdings in these shares, 300 lowered their positions, and 61 left no stake in the company.
The stock’s 9-day MACD is 0.8 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 51.88, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 42.72 percent, which is more when compared to that of the 50-day’s 33 percent. On the daily chart, we see that the stock could reach the first level of resistance at $37.27, sporting a 1.34% premium to the current level. The next resistance point is at $37.77, representing nearly 2.65% premium to the current market price of Boston Scientific Corporation (BSX). On the other hand, failure to breach the immediate hurdles can drag it down to $34.78, the lower end of the range.